Registry of X-linked Adrenoleukodystrophy

Sponsor
Beijing Tiantan Hospital
Study ID
NCT05939232
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Key Dates

Start date
Jul 20, 2023
Status verified
Jul 2023
Primary completion
Dec 1, 2028
Completion
Dec 1, 2028

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: X-ALD
    X-linked adrenoleukodystrophy (X-ALD) patients.
  • Arm: Carrier-control (CC)
    Carriers of mutation in gene encoding ATP-binding cassette subfamily D member 1 (ABCD1), who have no X-linked adrenoleukodystrophy and are matched with the X-ALD group according to age, sex and education.

Primary Outcome Measure

Epidemiological characteristics in Chinese X-ALD patients [ Time Frame: 5 years ]

Central Contacts

Related Studies